Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
New UPS distribution center in Taiwan doubles capacity, productivity - 2Reclassifying Achievement: Individual Accounts of Seeking after Interests
- 3Guaranteeing Quality Medical care with Federal medical care Benefit Plans.
- 4Daily Briefing: A bad flu season gets worse
- 5Marvel's X-Men are joining the battle in 'Avengers: Doomsday': Watch the teaser
- Heat Wave Fuels Massive Wildfire In Australia
- Bennu asteroid samples provide clues about solar system origins and 'space gum'
- Bullets in Luigi Mangione’s bag convinced police that he was UnitedHealthcare CEO killing suspect
- Scientists may be overestimating the amount of microplastics in the environment – and the culprit is lab gloves
- Manual for 10 Scrumptious Specialty Mixed drinks
- Banks for High Fixed Store Rates: Augment Your Investment funds
- Baidu robotaxi outage in Wuhan caused by 'system failure', police say
- The most effective method to Recognize a Great Lab Jewel
- Vote in favor of Your Number one BWM Vehicles
